Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

2.

Sleep deprivation in depression.

Hemmeter UM, Hemmeter-Spernal J, Krieg JC.

Expert Rev Neurother. 2010 Jul;10(7):1101-15. doi: 10.1586/ern.10.83. Review.

PMID:
20586691
3.

The mesolimbic dopamine system as a target for rapid antidepressant action.

Willner P.

Int Clin Psychopharmacol. 1997 Jul;12 Suppl 3:S7-14. Review.

PMID:
9347387
4.

Region-specific transcriptional changes following the three antidepressant treatments electro convulsive therapy, sleep deprivation and fluoxetine.

Conti B, Maier R, Barr AM, Morale MC, Lu X, Sanna PP, Bilbe G, Hoyer D, Bartfai T.

Mol Psychiatry. 2007 Feb;12(2):167-89. Epub 2006 Oct 10.

PMID:
17033635
5.

Sleep deprivation in depression: what do we know, where do we go?

Wirz-Justice A, Van den Hoofdakker RH.

Biol Psychiatry. 1999 Aug 15;46(4):445-53. Review.

PMID:
10459393
6.

Antidepressive response to sleep deprivation in unipolar depression is not associated with dopamine D3 receptor genotype.

Schumann G, Benedetti F, Voderholzer U, Kammerer N, Hemmeter U, Travers HW, Fiebich B, Holsboer-Trachsler E, Berger M, Seifritz E, Ebert D.

Neuropsychobiology. 2001;43(3):127-30.

PMID:
11287789
7.

Selective increase of dopamine D3 receptor gene expression as a common effect of chronic antidepressant treatments.

Lammers CH, Diaz J, Schwartz JC, Sokoloff P.

Mol Psychiatry. 2000 Jul;5(4):378-88.

PMID:
10889548
9.

The clinical response to total sleep deprivation and recovery sleep in geriatric depression: potential indicators of antidepressant treatment outcome.

Hernandez CR, Smith GS, Houck PR, Pollock BG, Mulsant B, Dew MA, Reynolds CF 3rd.

Psychiatry Res. 2000 Dec 4;97(1):41-9.

PMID:
11104856
11.

Therapeutic use of sleep deprivation in depression.

Giedke H, Schwärzler F.

Sleep Med Rev. 2002 Oct;6(5):361-77. Review.

PMID:
12531127
12.

Serotonin 5-HT2A receptor gene variants influence antidepressant response to repeated total sleep deprivation in bipolar depression.

Benedetti F, Barbini B, Bernasconi A, Fulgosi MC, Colombo C, Dallaspezia S, Gavinelli C, Marino E, Pirovano A, Radaelli D, Smeraldi E.

Prog Neuropsychopharmacol Biol Psychiatry. 2008 Dec 12;32(8):1863-6. doi: 10.1016/j.pnpbp.2008.08.017. Epub 2008 Sep 4.

PMID:
18801406
13.
14.

Phase advance is an actimetric correlate of antidepressant response to sleep deprivation and light therapy in bipolar depression.

Benedetti F, Dallaspezia S, Fulgosi MC, Barbini B, Colombo C, Smeraldi E.

Chronobiol Int. 2007;24(5):921-37.

PMID:
17994346
15.

Environmental regulation of the development of mesolimbic dopamine systems: a neurobiological mechanism for vulnerability to drug abuse?

Meaney MJ, Brake W, Gratton A.

Psychoneuroendocrinology. 2002 Jan-Feb;27(1-2):127-38. Review.

PMID:
11750774
16.

The antidepressant-sensitive dopamine transporter in Drosophila melanogaster: a primordial carrier for catecholamines.

Pörzgen P, Park SK, Hirsh J, Sonders MS, Amara SG.

Mol Pharmacol. 2001 Jan;59(1):83-95.

17.

Neurotransmitter systems of the medial prefrontal cortex: potential role in sensitization to psychostimulants.

Steketee JD.

Brain Res Brain Res Rev. 2003 Mar;41(2-3):203-28. Review.

PMID:
12663081
18.

[Antidepressant therapy by sleep deprivation (author's transl)].

Rudolf GA, Schilgen B, Tölle R.

Nervenarzt. 1977 Jan;48(1):1-11. German. No abstract available.

PMID:
191760
19.

Increased spontaneous eye blink rate following prolonged wakefulness.

Barbato G, De Padova V, Paolillo AR, Arpaia L, Russo E, Ficca G.

Physiol Behav. 2007 Jan 30;90(1):151-4. Epub 2006 Oct 27.

PMID:
17070878
20.

Mid-term effects of serial sleep deprivation therapy implemented in cognitive-behavioral treatment on the neuroendocrine response to clomipramine in patients with major depression.

Kundermann B, Strate P, Hemmeter-Spernal J, Huber MT, Krieg JC, Lautenbacher S.

J Psychiatr Res. 2009 Apr;43(7):711-20. doi: 10.1016/j.jpsychires.2008.09.004. Epub 2008 Oct 18.

PMID:
18930473

Supplemental Content

Support Center